Can early #ctDNA kinetics tell us more than PSA alone in #mCRPC?
This review examines ctDNA across ARPIs, chemotherapy, PARP inhibitors & PSMA-targeted radioligand therapy.
Read about the findings. https://bit.ly/4hepzeK
#ProstateCancer #LiquidBiopsy
